Does preadmission statin use reduce one-year mortality in patients in intensive care?
Preadmission statin use is associated with a reduced risk of one-year mortality among intensive care patients, though residual confounding remains a possibility.
Preadmission statin use was associated with reduced risk of death following intensive care. The associations seen could be a pharmacological effect of statins, but unmeasured differences in characteristics of statin users and non-users cannot be entirely ruled out.
Christensen et al. (Tue,) studied this question.